About Us

A New Era in Aortic Care

Despite decades of progress in structural heart intervention, treatment of the ascending aorta and aortic root continues to rely predominantly on highly invasive open surgical procedures.

Veritas was founded on the belief that patients and physicians deserve a fundamentally new solution, one purpose-built for transcatheter repair of the heart’s most critical vascular structures.

Our technologies are designed to address longstanding procedural challenges surrounding coronary perfusion, aortic root reconstruction, and ascending aortic repair through a unified endovascular approach.

Innovation with Purpose

Every aspect of the Veritas TVARC platform is guided by a singular objective: improving outcomes for patients with complex aortic disease.

We believe the future of cardiovascular intervention lies in integrated therapies that simplify treatment, reduce invasiveness, and enable physicians to treat critically ill patients with greater precision and confidence.

Through close collaboration with leading physicians, engineers, and strategic partners, Veritas is developing technologies intended to redefine what is possible in proximal aortic intervention.

Our Foundation

Veritas Aortic Solutions was founded and incubated within inQB8 Medical Technologies before becoming an independent company in late 2025.

Today, Veritas is advancing its mission to establish a new category in cardiovascular care, bringing next-generation transcatheter solutions to patients with complex aortic pathology worldwide.